Aim immunotech postpones investor conference call. will reschedule for a later date

Ocala, fla., jan. 11, 2021 (globe newswire) -- aim immunotech inc. (nyse american: aim) and its ceo thomas k. equels today announced that this week's planned investor conference call will be postponed and rescheduled for a later date following the death of mr. equels' mother over this past weekend.

AIM Ratings Summary

AIM Quant Ranking